copyright has built headlines before numerous months for not only the shortage but one among the main brings about from the claimed shortage. The drug is meant for patients with Type 2 diabetes, and it is a after-a-7 days injection.In Oct 2024, Novo Nordisk printed a research on scientific journal Nature a few novel glucose-sensitive insulin NNC221